PATENT CLAIM ANALYSIS

Application Number: 15750595
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "230200"]

Abstract:
The present invention relates to novel crystalline forms of dolutegravir, process for its preparation and pharmaceutical composition comprising them.

Claim (Index 22):
The process of  claim 19 , wherein the sodium hydroxide is an aqueous solution of sodium hydroxide.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15533595', '14905062', '13001715', '14344737', '13027523']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.826836534622766
- 35 USC 102 Novelty (BERT): 0.5695578049703484
- Combined Prediction Score: 0.8011086616575243
- Mean Citation Score: 415.504956
- Max Citation Score: 549.39343
- Similarity Product: 331.5072331545073

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test